In-stent restenosis: Contributions of inflammatory responses and arterial injury to neointimal hyperplasia

被引:729
|
作者
Kornowski, R
Hong, MK
Tio, FO
Bramwell, O
Wu, HS
Leon, MB
机构
[1] Washington Hosp Ctr, Dept Internal Med, Div Cardiol, Washington, DC 20010 USA
[2] Washington Hosp Ctr, Medlant Res Inst, Washington, DC 20010 USA
[3] Univ Texas, Hlth Sci Ctr, Dept Pathol, San Antonio, TX 78284 USA
关键词
D O I
10.1016/S0735-1097(97)00450-6
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objectives. We examined the relative contributions of inflammation and arterial injury to neointimal formation in a porcine coronary overstretch restenosis model. Background. Previous studies established that stents cause neointimal proliferation proportional to injury, Although inflammation has been postulated to be a major contributor to restenosis after angioplasty, there is a paucity of data on the relation between inflammation and subsequent neointimal formation. Methods. Twenty-one pigs underwent balloon injury followed by implantation of oversized, tubular, slotted stents (stent/artery ratio 1.2:1) in the left anterior descending coronary artery, Morphometric analysis of the extent of injury (graded as injury score 0 to 3) and inflammation (graded as inflammation score 0 to 3) 1 month later was assessed and correlated with neointimal formation. Results. An inflammatory reaction was observed in 20 of 21 pigs, and significant positive correlations were found between the degree of arterial injury and the extent of the inflammatory reaction (r = 0.80, p < 0.01) and between the extent of inflammatory reaction and the neointimal thickness (r = 0.75, p < 0.01), neointimal area (r = 0.53, p = 0.01) and percent area stenosis (r = 0.66, p < 0.01) within the stents, Importantly, there were areas with inflammation only in the absence of injury, and vice versa, that were also associated with neointimal hyperplasia. Conclusions. These data suggest that the inflammatory reaction plays an equally important role as arterial injury in neointimal formation after coronary stenting, and that, anti-inflammatory approaches may be of value to reduce in-stent restenosis. (C) 1998 by the American College of Cardiology.
引用
收藏
页码:224 / 230
页数:7
相关论文
共 50 条
  • [21] Radioactive stents delay but do not prevent in-stent neointimal hyperplasia
    Kay, IP
    Wardeh, AJ
    Kozuma, K
    Foley, DP
    Knook, AHM
    Thury, A
    Sianos, G
    van der Giessen, WJ
    Levendag, PC
    Serruys, PW
    CIRCULATION, 2001, 103 (01) : 14 - 17
  • [22] The magnitude of neointimal hyperplasia as a mechanism of in-stent restenosis in diabetes mellitus after sirolimus eluting stent implantation: A volumetric intravascular ultrasound study
    Sano, K
    Carlier, S
    Mintz, GS
    Fujii, K
    Costa, J
    Kimura, M
    Tanaka, K
    Dangas, GD
    Mehran, R
    Moussa, I
    Kreps, EM
    Collins, MB
    Stone, GW
    Moses, JW
    Leon, MB
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2006, 47 (04) : 10B - 10B
  • [23] Regrowth of neointimal effect of in-stent restenosis: A volumetric analysis of the effects of radiation
    Somrantin, M
    Morino, Y
    Limpijankit, T
    Honda, Y
    Mintz, GS
    Yock, PG
    Waksman, R
    Fitzgerald, PJ
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2001, 37 (02) : 41A - 42A
  • [24] The arterial inflammatory reaction at site of overlapping stents in a porcine coronary in-stent restenosis model
    Lim, S. Y.
    Jeong, M. H.
    Kim, J. H.
    Hong, Y. J.
    Kim, J. H.
    Ahn, Y. K.
    Kang, J. C.
    ATHEROSCLEROSIS SUPPLEMENTS, 2007, 8 (01) : 76 - 76
  • [25] Overstretch stent injury to the rat aorta leads to in-stent restenosis
    Lowe, HC
    Oesterle, SN
    MacNeill, BD
    James, B
    Chesterman, CN
    Khachigian, LM
    AMERICAN JOURNAL OF CARDIOLOGY, 2002, 89 (08): : 1010 - 1010
  • [26] Sirolimus-eluting stents abolish neointimal hyperplasia in patients with in-stent restenosis: Late angiographic and intravascular ultrasound results
    Serruys, PW
    Abizaid, A
    Foley, D
    Abizaid, A
    de Feyter, P
    Popma, J
    Degertakin, M
    Staico, R
    Pinto, L
    Wuelfert, E
    Sousa, A
    Sousa, JE
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2002, 39 (05) : 37A - 37A
  • [27] The Effects of Ramiprilat-Coated Stent on Neointimal Hyperplasia, Inflammation, and Arterial Healing in Porcine Coronary Restenosis Model
    Hong, Young Joon
    Jeong, Myung Ho
    Sim, Doo Sun
    Kim, Jung Ha
    Lim, Kyung Seob
    Hachinohe, Daisuke
    Ahmed, Khurshid
    Hwang, Seung Hwan
    Lee, Min Goo
    Park, Keun Ho
    Kim, Ju Han
    Ahn, Youngkeun
    Cho, Jeong Gwan
    Park, Jong Chun
    Kong, Jung Chaee
    AMERICAN JOURNAL OF CARDIOLOGY, 2011, 107 (8A): : 76A - 77A
  • [28] The interventionalist's dilemma: innocent intimal hyperplasia or in-stent restenosis?
    Pijls, NHJ
    EUROPEAN HEART JOURNAL, 2004, 25 (22) : 1970 - 1971
  • [29] Can low molecular heparin dalteparin inhibit in-stent neointimal hyperplasia following repeated PTCA to treat in-stent restenosis? A randomized trial followed by serial IVUS analysis
    Kotani, J
    Nanto, S
    Ohara, T
    Morozumi, T
    Watanabe, T
    Fujita, M
    Nishio, M
    Nagata, S
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2001, 37 (02) : 13A - 13A
  • [30] Positive remodeling, regression of in-stent neointimal hyperplasia, and late stent malapposition in the absence of brachytherapy
    Mintz, GS
    Weissman, NJ
    Pappas, C
    Waksman, R
    CIRCULATION, 2000, 102 (16) : E111 - E111